Donald Bergstrom
Chief Tech/Sci/R&D Officer at RELAY THERAPEUTICS, INC.
Net worth: 3 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| André Choulika | M | 59 |
Cellectis, Inc.
 Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The private company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | 25 years |
| David Sourdive | M | 57 | 25 years | |
| Alexis Borisy | M | 52 | 9 years | |
| John Valliant | M | 54 | 10 years | |
| Mark Murcko | M | 64 | 9 years | |
| Imogen Pryce | M | - | - | |
| Anna Protopapas | F | 59 | 9 years | |
| Sanjiv Patel | M | 50 | 7 years | |
| Brian Adams | M | 50 | 6 years | |
| Amanda Cray | F | - | - | |
| Lawrence Alleva | M | 74 | 7 years | |
| Douglas Ingram | M | 61 | 5 years | |
| Pablo Cagnoni | M | 60 | 5 years | |
| Willard Dere | M | 70 | 6 years | |
| Marie-Bleuenn Terrier | F | 42 | 16 years | |
| Philina Lee | M | 47 | 3 years | |
| Rainer Boehm | M | 63 | 7 years | |
| Sekar Kathiresan | M | 52 | 2 years | |
| Stephan Reynier | M | 55 | 13 years | |
| Andy Porter | M | - | 5 years | |
| Axel-Sven Malkomes | M | 57 | 2 years | |
| Andrew Hack | M | 50 | 7 years | |
| Kristen Hege | M | 60 | 8 years | |
| Barbara Duncan | F | 59 | 4 years | |
| Linda Hill | M | 67 | 6 years | |
| Jami Rubin | F | 60 | 5 years | |
| Laura Shawver | M | 66 | 7 years | |
| Laurent Arthaud | M | 61 | 13 years | |
| Mark Frattini | M | 58 | 4 years | |
| Pierre Bastid | M | 69 | 13 years | |
| Steven Gannon | M | 62 | 4 years | |
| Peter Rahmer | M | - | 4 years | |
| Cara Ferreira | M | - | 4 years | |
| Arthur Stril | M | 35 | 6 years | |
| Dmitri Bobilev | M | - | 2 years | |
| Patrick Riley | M | - | 3 years | |
| Kyung Nam-Wortman | F | 54 | 4 years | |
| Pascalyne Wilson | M | - | - | |
| Mohit Rawat | M | - | 3 years | |
| Steve Doares | M | - | 4 years | |
| Jeanne Gray | F | - | - | |
| David Meek | M | 59 | 1 years | |
| Ben Wolf | M | - | 5 years | |
| Thomas Catinazzo | M | 47 | 6 years | |
| Dan Budwick | M | - | - | |
| Teresa Bitetti | F | - | 1 years | |
| John Crowley | M | 51 | 5 years | |
| Jeremy Bender | M | 52 | 1 years | |
| Philippe Duchateau | M | 61 | 23 years | |
| Eric Burak | M | - | 7 years | |
| Maria D. Stahl | F | 53 | 4 years | |
| Eric S. Hoffman | M | 54 | 3 years | |
| Christopher Leamon | M | 57 | 3 years | |
| Jean-Pierre Garnier | M | 75 | 4 years | |
| Cécile Chartier | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chau Khuong | M | 48 | 4 years | |
| Elaine Jones | M | 69 | 3 years | |
| Johan Rutger Christenson | M | 65 | 6 years | |
| Annick Schwebig | M | 73 | 12 years | |
| Dipchand Nishar | M | 55 | 2 years | |
| Steven Kafka | M | 54 | 1 years | |
| Gregory Irace | M | 65 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | 4 years |
| Christoph S. Lengauer | M | 59 | - | |
| Lynn Wick | F | - | 4 years | |
| Herve Hoppenot | M | 64 | 6 years | |
| Heather Elizabeth Preston | M | 58 | 4 years | |
| Rosina B. Dixon | M | 81 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | 5 years |
| Michael J. Kaufman | M | 66 | 5 years | |
| Stefan Schwabe | M | 72 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | 4 years |
| Margaret Gandolfo | F | - | - | |
| David Spellman | M | 48 | 1 years | |
| Bing C. Wang | M | 47 | 2 years | |
| Carrie Brownstein | M | 54 | 2 years | |
| Isabelle Dussault | M | - | 1 years | |
| David Malek | M | 47 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | 5 years |
| Deborah Palestrant | M | - | 1 years | |
| Markus Warmuth | M | 53 | 1 years | |
| Debasish Francois Roychowdhury | M | 63 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | 4 years |
| Christer Odqvist | M | - |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | 9 years |
| Donna M. Jarlenski | F | - | 6 years | |
| Nigel Brooksby | M | - |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | - |
| Jean-Pierre Lehner | M | - |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | - |
| David Noskowitz | M | - | 2 years | |
| James J. O'Leary | M | 60 | 2 years | |
| Pankaj Bhargava | M | 54 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | 3 years |
| Alain Munoz | M | 75 | - | |
| Jaideep Dudani | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 43 | 49.43% |
| France | 22 | 25.29% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Donald Bergstrom
- Personal Network